A Phase 2, Randomized, Placebo-controlled, Double-blind Study of EG017 in Female Patients With Stress Urinary Incontinence

NCT05674045 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

51

Enrollment

INDUSTRY

Sponsor class

Conditions

Stress Urinary Incontinence

Interventions

DRUG: EG017 3mg
DRUG: EG017 6mg

Sponsor

Changchun GeneScience Pharmaceutical Co., Ltd.

Collaborators

[object Object]